India Pharma - IPM Growth Momentum Fortifies In October, Partly Aided By Low Base: Motilal Oswal

The monthly YoY growth ha Motilal Oswal u Indian for MNC r months now.

The low base aided superior growth in Oct-23.

For the 12 months ended October-23, prices/volumes/new launches reported 4.6%/3.8% growth. India ass="summaryFeed_highLightText__NxlGi">Original DISCLAIMER the 12 months e Motilal Oswal Report India s="summaryFeed_highLig 16.5% t YoY xlGi October 2023 3.3% ="su October 2023 ghLig 8.6% xt__ September 2023 8%/3.0% monthly YoY pan class="summaryFeed_highLightTex four months 1.5% Oct-23 /span> YoY span class="summaryFeed_highLightText__NxlGi">the 12 months ended Oct-23 YoY pan> YoY Y YoY hig Ophthal ext__NxlGi">800 IPM